EPISODE 034: "Biopiracy: When Genetic Treasures Become Corporate Gold"
BIOPIRACY | Indigenous Rights | Pharmaceutical Patents | Genetic Resources | Traditional Knowledge | Biotechnology Ethics
Explore how pharmaceutical companies exploit indigenous communities by patenting traditional knowledge and genetic resources without consent or compensation. This episode examines unauthorized appropriation of biological materials in the $1.42 trillion global pharmaceutical market while original knowledge holders receive nothing.
KEY TOPICS COVERED:
Understanding Biopiracy
Difference between legitimate bioprospecting and biopiracy
Unauthorized extraction of genetic resources from indigenous communities
$152 billion herbal supplement industry built on traditional knowledge
Economic exploitation of biodiversity hotspots in developing nations
Infamous Cases
Neem tree: 2,000 years of Indian traditional knowledge patented by U.S. companies
Hoodia cactus: San people's appetite suppressant exploited by Pfizer and Unilever
Basmati rice: RiceTec's patent on centuries-old Indian agricultural heritage
Stevia: Guaraní traditional knowledge in multi-billion dollar sweetener market
Madagascar periwinkle: Lifesaving leukemia drugs with zero origin compensation
Legal Framework
Convention on Biological Diversity and Nagoya Protocol
TRIPS agreement and patent law challenges
India's Biological Diversity Act and Traditional Knowledge Digital Library
World Intellectual Property Organization negotiations
Technology Solutions
Manufacturing Execution Systems for transparency and traceability
Blockchain technology for immutable consent records
Artificial intelligence for patent screening
Digital Sequence Information challenges and solutions
Ethical Frameworks
Prior informed consent and benefit-sharing agreements
Community-based protocols for knowledge protection
Union for Ethical BioTrade certification
Collaborative innovation replacing extractive practices
Perfect for:
Pharmaceutical manufacturing professionals
Biotechnology researchers and patent attorneys
Regulatory affairs and compliance specialists
Supply chain transparency professionals
Indigenous rights and environmental justice advocates
Featured Companies & Technologies: Pfizer | Unilever | Novo Nordisk | RiceTec | Shaman Pharmaceuticals | Apprentice.io Tempo Platform | Traditional Knowledge Digital Library | Earth Bank of Codes
Host: Frank Maggiore
Series: Apprentice.io Industry Insights Podcast
#Biopiracy #IndigenousRights #TraditionalKnowledge #PharmaceuticalPatents #GeneticResources #Biotechnology #EthicalBioprospecting #NagoyaProtocol #BiodiversityConservation #IntellectualProperty #SupplyChainTransparency #ManufacturingExecutionSystems #CloudMES #CorporateResponsibility #Sustainability #EnvironmentalJustice #DrugDiscovery #PatentLaw #BenefitSharing #CulturalHeritage
ENGAGE WITH US: Like this video if you found it valuable Comment with your thoughts on biopiracy and ethical innovation Subscribe for weekly science-based pharmaceutical insights Share with colleagues in pharma, biotech, and regulatory affairs
Learn more about cloud-based manufacturing solutions: apprentice.io
Disclaimer: The content in this video podcast is for informational purposes only. The views and opinions expressed are those of the speakers and do not necessarily reflect the official policy or position of Apprentice.io or any other agency, organization, employer or company. This podcast does not constitute medical, financial, regulatory, or legal advice. Viewers should consult with appropriate professionals for specific advice. Apprentice.io makes no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability of the information contained in this video. Any reliance you place on such information is strictly at your own risk.
Related Topics: Convention on Biological Diversity, access and benefit sharing, prior informed consent, patent infringement, indigenous intellectual property, bioprospecting agreements, genetic sovereignty, TRIPS agreement, pharmaceutical supply chain, traditional medicine systems, Ayurvedic knowledge, ethnobotany, plant-based medicines, natural product discovery, clinical trial ethics, regulatory compliance, biodiversity protection, sustainable harvesting, geographic indication, digital manufacturing, traceability systems
Информация по комментариям в разработке